Literature DB >> 21410689

Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi.

Maria G Matera1, Luigino Calzetta, Daniela Passeri, Francesco Facciolo, Erino A Rendina, Clive Page, Mario Cazzola, Augusto Orlandi.   

Abstract

BACKGROUND AND PURPOSE Brain natriuretic peptide (BNP) plays an important role in several biological functions, including bronchial relaxation. Here, we have investigated the role of BNP and its cognate receptors in human bronchial tone. EXPERIMENTAL APPROACH Effects of BNP on responses to carbachol and histamine were evaluated in non-sensitized, passively sensitized, epithelium-intact or denuded isolated bronchi and in the presence of methoctramine, N(ω) -nitro-L-arginine methyl ester (L-NAME) and aminoguanidine. Natriuretic peptide receptors (NPRs) were investigated by immunohistochemistry, RT-PCR and real-time PCR. Release of NO and acetylcholine from bronchial tissues and cultured BEAS-2B bronchial epithelial cells was also investigated. KEY RESULTS BNP reduced contractions mediated by carbachol and histamine, with decreased E(max) (carbachol: 22.7 ± 4.7%; histamine: 59.3 ± 1.8%) and increased EC(50) (carbachol: control 3.33 ± 0.88 µM, BNP 100 ± 52.9 µM; histamine: control 16.7 ± 1.7 µM, BNP 90 ± 30.6 µM); BNP was ineffective in epithelium-denuded bronchi. Among NPRs, only atrial NPR (NPR1) transcripts were detected in bronchial tissue. Bronchial NPR1 immunoreactivity was detected in epithelium and inflammatory cells but faint or absent in airway smooth muscle cells. NPR1 transcripts in bronchi increased after incubation with BNP, but not after sensitization. Methoctramine and quinine abolished BNP-induced relaxant activity. The latter was associated with increased bronchial mRNA for NO synthase and NO release, inhibited by L-NAME and aminoguanidine. In vitro, BNP increased acetylcholine release from bronchial epithelial cells, whereas NO release was unchanged. CONCLUSIONS AND IMPLICATIONS Epithelial cells mediate the BNP-induced relaxant activity in human isolated bronchi.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21410689      PMCID: PMC3166700          DOI: 10.1111/j.1476-5381.2011.01339.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  62 in total

1.  Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium.

Authors:  Katrin Susanne Lips; Christopher Volk; Bernhard Matthias Schmitt; Uwe Pfeil; Petra Arndt; Dagmar Miska; Leander Ermert; Wolfgang Kummer; Hermann Koepsell
Journal:  Am J Respir Cell Mol Biol       Date:  2005-04-07       Impact factor: 6.914

2.  Propionyl-L-carnitine reduces proliferation and potentiates Bax-related apoptosis of aortic intimal smooth muscle cells by modulating nuclear factor-kappaB activity.

Authors:  Augusto Orlandi; Arianna Francesconi; Marcella Marcellini; Antonio Di Lascio; Luigi Giusto Spagnoli
Journal:  J Biol Chem       Date:  2006-12-17       Impact factor: 5.157

Review 3.  Muscarinic receptors and control of airway smooth muscle.

Authors:  A D Fryer; D B Jacoby
Journal:  Am J Respir Crit Care Med       Date:  1998-11       Impact factor: 21.405

Review 4.  Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions.

Authors:  Lincoln R Potter; Sarah Abbey-Hosch; Deborah M Dickey
Journal:  Endocr Rev       Date:  2005-11-16       Impact factor: 19.871

5.  In vivo release of non-neuronal acetylcholine from the human skin as measured by dermal microdialysis: effect of botulinum toxin.

Authors:  Tanja Schlereth; Frank Birklein; Katrin an Haack; Susanne Schiffmann; Heinz Kilbinger; Charles James Kirkpatrick; Ignaz Wessler
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

6.  Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implications.

Authors:  Augusto Orlandi; Amedeo Ferlosio; Alessandro Ciucci; Arianna Francesconi; Beatriz Lifschitz-Mercer; Giulio Gabbiani; Luigi G Spagnoli; Bernard Czernobilsky
Journal:  Mod Pathol       Date:  2006-06       Impact factor: 7.842

7.  Mechanisms involved in the regulation of mRNA for M2 muscarinic acetylcholine receptors and endothelial and neuronal NO synthases in rat atria.

Authors:  S Ganzinelli; L Joensen; E Borda; G Bernabeo; L Sterin-Borda
Journal:  Br J Pharmacol       Date:  2007-03-26       Impact factor: 8.739

8.  Bronchodilator effect of infused B-type natriuretic peptide in asthma.

Authors:  Michael J Akerman; Makito Yaegashi; Zothanmawii Khiangte; Anandhi T Murugan; Olumayowa Abe; Jonathan D Marmur
Journal:  Chest       Date:  2006-07       Impact factor: 9.410

Review 9.  Mechanisms of immune sensitization of human bronchus.

Authors:  K F Rabe
Journal:  Am J Respir Crit Care Med       Date:  1998-11       Impact factor: 21.405

Review 10.  Muscarinic receptor signaling in the pathophysiology of asthma and COPD.

Authors:  Reinoud Gosens; Johan Zaagsma; Herman Meurs; Andrew J Halayko
Journal:  Respir Res       Date:  2006-05-09
View more
  11 in total

1.  Mediastinal germ cell tumors: new therapeutic insights.

Authors:  Amedeo Ferlosio; Alessandra Bielli; Augusto Orlandi
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

2.  In vitro and in vivo pharmacological profile of PL-3994, a novel cyclic peptide (Hept-cyclo(Cys-His-Phe-d-Ala-Gly-Arg-d-Nle-Asp-Arg-Ile-Ser-Cys)-Tyr-[Arg mimetic]-NH(2)) natriuretic peptide receptor-A agonist that is resistant to neutral endopeptidase and acts as a bronchodilator.

Authors:  Jeffrey D Edelson; Marie Makhlina; Kevin R Silvester; Shailesh S Vengurlekar; Xiaomei Chen; Jie Zhang; Cynthia J Koziol-White; Philip R Cooper; Trevor J Hallam; Douglas W P Hay; Reynold A Panettieri
Journal:  Pulm Pharmacol Ther       Date:  2012-11-12       Impact factor: 3.410

3.  V0162 a new long-acting bronchodilator for treatment of chronic obstructive lung diseases: preclinical and clinical results.

Authors:  Philippe Devillier; Eric Garrigue; Guillaume D'Auzers; Nicolas Monjotin; Thomas Similowski; Thierry Clerc
Journal:  Respir Res       Date:  2015-06-08

4.  Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.

Authors:  Mario Cazzola; Luigino Calzetta; Francesco Facciolo; Paola Rogliani; Maria Gabriella Matera
Journal:  Respir Res       Date:  2017-01-24

5.  Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways.

Authors:  Luigino Calzetta; Maria Gabriella Matera; Francesco Facciolo; Mario Cazzola; Paola Rogliani
Journal:  Respir Res       Date:  2018-04-12

6.  Regulation of smooth muscle contractility by the epithelium in rat tracheas: role of prostaglandin E2 induced by the neurotransmitter acetylcholine.

Authors:  Lei Zhao; Yu-Ting Liang; Dong-Bo Tian; Rui-Gang Zhang; Jiehong Huang; Yun-Xin Zhu; Wen-Liang Zhou; Yi-Lin Zhang
Journal:  Ann Transl Med       Date:  2021-02

7.  TNF-α regulates natriuretic peptides and aquaporins in human bronchial epithelial cells BEAS-2B.

Authors:  Letizia Mezzasoma; Lucio Cagini; Cinzia Antognelli; Francesco Puma; Eugenio Pacifico; Vincenzo Nicola Talesa
Journal:  Mediators Inflamm       Date:  2013-11-28       Impact factor: 4.711

8.  High expression of cellular retinol binding protein-1 in lung adenocarcinoma is associated with poor prognosis.

Authors:  Elena Doldo; Gaetana Costanza; Amedeo Ferlosio; Eugenio Pompeo; Sara Agostinelli; Guido Bellezza; Donatella Mazzaglia; Alessandro Giunta; Angelo Sidoni; Augusto Orlandi
Journal:  Genes Cancer       Date:  2015-11

9.  Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells.

Authors:  Mario Cazzola; Luigino Calzetta; Ermanno Puxeddu; Josuel Ora; Francesco Facciolo; Paola Rogliani; Maria Gabriella Matera
Journal:  Respir Res       Date:  2016-06-13

10.  Caveolin-3 differentially orchestrates cholinergic and serotonergic constriction of murine airways.

Authors:  M Keshavarz; M Skill; M I Hollenhorst; S Maxeiner; M Walecki; U Pfeil; W Kummer; G Krasteva-Christ
Journal:  Sci Rep       Date:  2018-05-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.